Paragon 28 introduced new demineralized bone matrices BEAST™ Injectable Putty, BEAST PLUS™ and BEAST™ Osteobiologic Sponge (BOB™).
The grafts have a high osteoinductive potential and are processed using a proprietary method which ensures preservation of native bone morphogenic proteins, notably 2, 4, and 7.
BEAST Injectable Putty may be injected or molded and comes preloaded in a syringe. It is premixed with cortical chips to create BEAST PLUS, eliminating the need for intra-operative mixing. BEAST Osteobiologic Sponge is made from 100% human trabecular bone and has malleable properties that enable it to fill and conform to irregular bony defects.
“We are very excited about this addition to our biologics portfolio and the continued expansion in this segment,” said Executive Vice President of Marketing, Brendan Shook. “These products will complement our existing solutions and allow surgeons versatility in addressing complex cases.”
Paragon 28 introduced new demineralized bone matrices BEAST™ Injectable Putty, BEAST PLUS™ and BEAST™ Osteobiologic Sponge (BOB™).
The grafts have a high osteoinductive potential and are processed using a proprietary method which ensures preservation of native bone morphogenic proteins, notably 2, 4, and 7.
BEAST Injectable Putty may be...
Paragon 28 introduced new demineralized bone matrices BEAST™ Injectable Putty, BEAST PLUS™ and BEAST™ Osteobiologic Sponge (BOB™).
The grafts have a high osteoinductive potential and are processed using a proprietary method which ensures preservation of native bone morphogenic proteins, notably 2, 4, and 7.
BEAST Injectable Putty may be injected or molded and comes preloaded in a syringe. It is premixed with cortical chips to create BEAST PLUS, eliminating the need for intra-operative mixing. BEAST Osteobiologic Sponge is made from 100% human trabecular bone and has malleable properties that enable it to fill and conform to irregular bony defects.
“We are very excited about this addition to our biologics portfolio and the continued expansion in this segment,” said Executive Vice President of Marketing, Brendan Shook. “These products will complement our existing solutions and allow surgeons versatility in addressing complex cases.”
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
